The Atypical HUS Foundation

When I was reading the slides from the conference I came across the above. I don't really know much about this. On the European Medicines Agency I found out that the orphan designation was granted in 2007 for the development of Factor H and it is thought that the supplementation of purified factor H would alleviate the disease. It also says that the evaluation of the effects of complement factor H in experimental models is ongoing.
It was in 2007...would anybody know whether there's been any progress with this? Could this actually mean that it would have the potential to restore a normal capacity to regulate complement activity. I would be grateful for any information.

Views: 29


You need to be a member of The Atypical HUS Foundation to add comments!

Join The Atypical HUS Foundation

Comment by Cheryl Biermann on November 8, 2009 at 10:30pm
Sylwia, good luck, it's all highly secretive until someone has a major break through and then publishes something.
Comment by Sylwia Antkowiak on November 8, 2009 at 1:00pm
Thank you Cheryl for all the info, I will try to obtain the up to date info on this.



© 2018   Created by Deborah Lewis.   Powered by

Badges  |  Report an Issue  |  Terms of Service